Skip to content

L-PRF augmented dural closure in elective intracranial surgery

L-PRF augmented dural closure in elective intracranial surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032103
Enrollment
205
Registered
2025-03-20
Start date
2025-01-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G97.80

Interventions

Group 1: Dural Closure augmented with L-PRF alone Group 2: Conventional dural closure with synthetic materials and without augmentation using L-PRF

Sponsors

Klinik für Neurochirurgie, Universitätsklinikum Frankfurt am Main
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Elective resection of sellar tumors (pituitary adenomas), elective craniotomy and resction of supratentorial lesions, elective craniotomy and resection of infratentorial lesions, age > 18 years

Exclusion criteria

Exclusion criteria: Age <18 years, preoperative signs of boney destruction of the skull or skull base, patients undergoing repeat surgical intervention, obvious intraoperative CSF fistula among patients undergoing transsphenoidal surgery.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the number of occurences of postoperative rhinoliquorrhea/CSF fistulas. This will be compared between patients underoing dural closure with L-PRF with and without synthetic materials and syntheic materials alone within 3 months following initial surgical intervention.

Secondary

MeasureTime frame
Secondary outcomes include: the time of occurence of possible CSF fistulas, the number and form of L-PRF products used intraoperatively, MRI characteristics of pre and postoperative tumor volume, Knosp-Grades (among pituitary adenomas) and contrast agent enrichment, occurence of infections and length of surgery.

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026